Abstract
One-third of all primary central nervous system tumors in adults are meningiomas. Rarely, meningiomas occur at multiple sites, usually occurring in individuals with type 2 neurofibromatosis (NF2). We sequenced the exomes of three unrelated individuals with familial multiple spinal meningiomas without NF2 mutations. We identified two individuals with heterozygous loss-of-function mutations in the SWI/SNF chromatin-remodeling complex subunit gene SMARCE1. Sequencing of SMARCE1 in six further individuals with spinal meningiomas identified two additional heterozygous loss-of-function mutations. Tumors from individuals with SMARCE1 mutations were of clear-cell histological subtype, and all had loss of SMARCE1 protein, consistent with a tumor suppressor mechanism. Our findings identify multiple-spinal-meningioma disease as a new discrete entity and establish a key role for the SWI/SNF complex in the pathogenesis of both meningiomas and tumors with clear-cell histology. © 2013 Nature America, Inc. All rights reserved.
Original language | English |
---|---|
Pages (from-to) | 295-298 |
Number of pages | 3 |
Journal | Nature Genetics |
Volume | 45 |
Issue number | 3 |
DOIs | |
Publication status | Published - Mar 2013 |
Keywords
- Adolescent
- Adult
- Base Sequence
- Chromosomal Proteins, Non-Histone/*genetics/metabolism
- Chromosome Deletion
- DNA-Binding Proteins/*genetics/metabolism
- Female
- Humans
- Loss of Heterozygosity
- Male
- *Meningeal Neoplasms/genetics/pathology
- *Meningioma/genetics/pathology
- Middle Aged
- Molecular Sequence Data
- *Mutation
- Neurofibromatosis 2/genetics/metabolism
- Polymorphism, Single Nucleotide